Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1465-1473

  Vairaktaris, Eleftherios ^a   Kalokerinos, Giorgos ^a   Goutzanis, Lambros ^a   Spyridonidou, Sofia ^a   Vassiliou, Stavros ^a   Derka, Spyridoula ^a   Nkenke, Emeka ^b   Yapijakis, Christos ^a,b   Vylliotis, Antonis ^a   Lazaris, Andreas ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

c myc; Diabetes; Histological grade; Immunohistochemistry; Oral cancer; p53

Indexed keywords

MYC PROTEIN; PROTEIN P53;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249274940     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Beenken SW and Urist MM: Head and neck tumors. In: Current Surgical Diagnosis and Treatment. Way LW, Doherty GM (eds.). 11th ed. New York, Lange Medical Books/McGraw-Hill, pp. 282-297, 2003.
2. Coleman JJ and Sultan MR: Tumors of the head and neck. In: Principles of Surgery. Schwartz SI (ed). 7th edition. New York, McGraw-Hill. pp. 601-665, 1999.
3. Massano J, Regateiro FS, Januario G and Ferreira A: Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102(1): 67-76, 2006.
4. Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36: 256-263, 2000.
5. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408(6810): 307-310, 2000.
6. Nylander K, Dabelsteen E and Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29(9): 413-425, 2000.
7. Ko LJ and Prives C: p53: puzzle and paradigm. Genes Dev 10(9): 1054-1072, 1996.
8. Prives C and Hall PA: The p53 pathway. J Pathol 187(1): 112-126, 1999.
9. Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A and Goldfinger N: Does wild-type p53 play a role in normal cell differentiation? Semin Cancer Biol 5(3): 229-236, 1994.
10. Whyte DA, Broton CE and Shillitoe EJ: The unexplained survival of cells in oral cancer: what is the role of p53? J Oral Pathol Med 31(3): 125-133, 2002.
11. Peller S: Clinical implications of p53: effect on prognosis, tumour progression and chemotherapy response. Cancer Biol 8: 379-387, 1998.
12. Xu J, Gimenez-Conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, Spitz MR and Conti CJ: Alterations of p53, cyclin D, Rb and H-ras in human oral carcinomas related to tobacco use. Cancer 83(2): 204-212, 1998.
13. Santos-Garcia A, Abad-Hernandez MM, Fonseca-Sanchez E, Cruz-Hernandez JJ and Bullon-Sopelana A: Proteic expression of p53 and cellular proliferation in oral leukoplakias. Med Oral Patol Oral Cir Bucal 10(1): 5-8; 1-5, 2005.
14. Kerdpon D, Rich AM and Reade PC: Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 3(2): 86-92, 1997.
15. Papakosta V, Vairaktaris E, Vylliotis A, Derka S, Nkenke E, Vassiliou S, Lazaris A, Mourouzis C, Rallis G, Spyridonidou S, Anagnostopoulou S, Perrea D, Donta I, Yapijakis C and Patsouris E: The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis. Anticancer Res 26(4B): 2957-2962, 2006.
16. Vermeulen K, Berneman ZN and Bockstaele DRV: Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003.
17. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Sumegi J, Klein G and Deo MG: Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 80: 430-437, 1989.
18. Eversole LR and Sapp JP: c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Eur J Cancer B Oral Oncol 29B(2): 131-135, 1993.
19. Vora HH, Shah NG, Patel DD, Trivedi TI and Chikhlikar PR: Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82: 34-50, 2003.
20. Dietrich T, Reichart PA and Scheifele C: Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol 40(2): 158-163, 2004.
21. Ujpal M, Matos O, Bibok G, Somogyi A, Szabo G and Suba Z: Diabetes and oral tumors in Hungary: epidemiological correlations. Diabetes Care 27(3): 770-774, 2004.
22. Goutzanis L, Vairaktaris E, Yapijakis C, Kavantzas N, Nkenke E, Derka S, Vassiliou S, Acil Y, Kessler P, Stavrianeas N, Perrea D, Donta I, Skandalakis P and Patsouris E: Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43(2): 165-173, 2007.
23. Kaneto H, Sharma A, Suzuma K, Laybutt DR, Xu G, Bonner-Weir S and Weir GC: Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation. J Biol Chem 277(15): 12998-13006, 2002.
24. Bonner-Weir S: Islet growth and development in the adult. J Mol Endocrinol 24: 297-302, 2000.
25. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S and Weir GC: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 20: 14112-14121, 1999.
26. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S and Weir GC: Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 278(5): 2997-3005, 2003.
27. Allen DA, Yaqoob MM and Harwood SM: Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 16(12): 705-713, 2005.
28. Derka S, Vairaktaris E, Papakosta V, Vassiliou S, Acil Y, Vylliotis A, Spyridonidou S, Lazaris AC, Mourouzis C, Kokkori A, Moulavasili P, Perrea D, Donta I, Yapijakis C and Patsouris E: Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 42(5): 540-550, 2006.
29. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P and Kajstura J: Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50: 2363-2375, 2001.
30. Kria L, Khalfaoui T, Mkannez G, Beltaief O, Anane R, Errais K, Tounsi L, Zhioua R, Ben Jilani S and Meddeb Ouertani A: Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients. J Mol Histol 36: 381-390, 2005.
31. Miyashita T and Reed JC: Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 31: 293-299, 1995.
32. Haldar S, Negrini M, Monne M, Sabbioni S and Croce C: Down-regulation of bcl-2 in breast cancer cells. Cancer Res 31: 2095-2097, 1994.
33. Vairaktaris E, Kalokerinos G, Goutzanis L, Yapijakis C, Derka S, Vassiliou S, Spyridonidou S, Vylliotis A, Nkenke E, Lazaris A and Patsouris E: Diabetes enhances cell proliferation but not apoptosis during oral oncogenesis. Int J Oral Maxillof Surg, 2007 (in press).
34. Rochlitz CF, Heide I, Thiede C, Hermann R and de Kant E: Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastases. Ann Oncol 31: 981-986, 1995.
35. Reisman D, Elkind NB, Roy B, Beamon J and Rotter V: c-Myc transactivates the p53 promoter through a required CACGTG motif. Cell Growth Diff 31: 57-65, 1993.